Other potential risks Skin reactions: Adhesives and herbal extracts may cause irritation, rashes, or allergic responses that can last for days
Differential antidiabetic efficacy of incretin agonists versus DPP-4 inhibition in high fat fed mice
By reducing the reward aspect of eating and making the person feel more full, the drugs may be able to treat binge eating
Research into thymosin beta-4 began in the late twentieth century and led to the development of TB-500 as a synthetic research peptide
TM30338, a dual Y 2 -Y 4 receptor agonist that leads to an acute reduction in food intake, and TM30339, a selective Y 4 receptor agonist, which is likely to be the subject of phase I/II study in the near future
Compounding pharmacies sometimes produced GLP-1 drugs in varying concentrations and packaging, which could confuse patients